Associated Banc-Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Associated Banc-Corp's XBI Position: Q1 2026 in Review
Associated Banc-Corp increased its State Street SPDR S&P Biotech ETF (XBI) stake by 12% in Q1 2026, buying an estimated $89.5K and bringing the position to 6,799 shares worth $868K. The position accounts for 0.02% of the portfolio, ranked #214.
Associated Banc-Corp first reported a position in XBI in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.2M in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Associated Banc-Corp held 6,799 shares of State Street SPDR S&P Biotech ETF worth $868K as of Q1 2026.
- Associated Banc-Corp bought 717 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $89.5K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Associated Banc-Corp's portfolio in Q1 2026, its #214 holding.
- Associated Banc-Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 16 quarters since.
- Associated Banc-Corp's State Street SPDR S&P Biotech ETF position peaked at $1.2M in Q3 2024.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.